726 results on '"Borte, Michael"'
Search Results
2. The GAIN Registry — a New Prospective Study for Patients with Multi-organ Autoimmunity and Autoinflammation
3. Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
4. BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children
5. Impfen in schwierigen Situationen
6. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
7. Maternal stress, child behavior and the promotive role of older siblings
8. Effects of exposure to single and multiple parabens on asthma development in an experimental mouse model and a prospective cohort study
9. Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies
10. Impfungen
11. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
12. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
13. Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study
14. Skabies – Renaissance einer Ektoparasitose: Diagnostik und Therapie – Vorgehen in der Praxis
15. Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
16. Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis
17. Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials
18. Maternal paraben exposure triggers childhood overweight development
19. Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency
20. Junge mit Verdacht auf eine bakterielle Meningitis
21. Global hypomethylation in childhood asthma identified by genome‐wide DNA ‐methylation sequencing preferentially affects enhancer regions
22. Early maternal perceived stress and children’s BMI: longitudinal impact and influencing factors
23. BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children
24. Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2
25. Langfristige Wirksamkeit und Sicherheit von Canakinumab bei Patienten mit TRAPS (Tumornekrosefaktor-Rezeptorassoziiertes periodisches Syndrom) – Zwischenanalyse des RELIANCE-Registers
26. Impfsicherheit unter Canakinumab bei Patienten mit autoinflammatorischen periodischen Syndromen – Interimsanalyse des RELIANCE-Registers
27. Langzeitsicherheit und Wirksamkeit von Canakinumab bei Cryopyrin-assoziierten periodischen Syndromen (CAPS) – 36-Monats-Daten aus dem RELIANCE-Register
28. Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease
29. Clinical picture and treatment of 2212 patients with common variable immunodeficiency
30. Maternal and cord blood miR-223 expression associates with prenatal tobacco smoke exposure and low regulatory T-cell numbers
31. Maternal phthalate exposure promotes allergic airway inflammation over 2 generations through epigenetic modifications
32. Mehr als nur eine juvenile idiopathische Arthritis
33. MEST mediates the impact of prenatal bisphenol A exposure on long-term body weight development
34. Metabolomics reveals effects of maternal smoking on endogenous metabolites from lipid metabolism in cord blood of newborns
35. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
36. Long-term safety of facilitated subcutaneous immunoglobulin treatment in pregnant women with primary immunodeficiency diseases: results from a registry study
37. Pro-inflammatory Diet Pictured in Children With Atopic Dermatitis or Food Allergy: Nutritional Data of the LiNA Cohort
38. 'Besser arm und gesund als reich und krank?' : Zur Allergieentstehung im frühen Kindesalter und deren Zusammenhang mit der Sozialschichtzugehörigkeit
39. Additional file 1 of Maternal stress, child behavior and the promotive role of older siblings
40. Real-world utilization, safety and patient experience of 20% subcutaneous immunoglobuin in patients with primary immunodeficiencies: final data from the core study
41. Genetic association between obstructive bronchitis and enzymes of oxidative stress
42. Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases
43. Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4+ and CD8+ T cells—clinical applications in primary immunodeficiency diagnostics
44. Period-Specific Growth, Overweight and Modification by Breastfeeding in the GINI and LISA Birth Cohorts up to Age 6 Years
45. Btk is a positive regulator in the TREM-1/DAP12 signaling pathway
46. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
47. Pharmacoeconomic Evaluation of Immunoglobulin Treatment in Patients with Antibody Deficiencies from the Perspective of the German Statutory Health Insurance
48. Assessment of maternal drug intake by urinary bio monitoring during pregnancy and postpartally until the third perinatal year
49. Increased vitamin D levels at birth and in early infancy increase offspring allergy risk—evidence for involvement of epigenetic mechanisms
50. Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.